30 Sep Medi-Guardian Newsletter September 2026
Posted at 20:08h
in
The aim of this newsletter is to disseminate regulatory information on post-marketing surveillance and pharmacovigilance activities rendered by SAHPRA, which includes responsibilities of the SAHPRA Pharmacovigilance unit, reporting tools and pharmacovigilance systems in the country.
Download latest version
Document Number:
PV04-2026/27
Version:
1
Date Updated:
30/09/2026
File Type:
www
Category:
Newsletter